mCig's investment in Omni is just under 10%. It does not give mCig control over the company. The only leverage it has is to sell it's shares and at the current pps it would not make any sense for it to do so. Even if it wanted to, selling on the open market would be impractical since it would have to be announced and that would drive down the pps even further.
Most of the shares mCig owns were not purchased or acquired. They are what's left from mCig's original spin off of VitaCig as a separate company and then selling the shell to Omni. Prior to that sale, Paul did not know Andrey or have any connection to LX Retail (the new majority shareholder). mCig's DD indicated that LX Retail was well financed and that Malecon was profitable. Consequently, the sale seemed to be a good move for VitaCig/Omni shareholders. At the time of the sale, VitaCig was trading under $.006/share. Since the sale it's traded as high as $.06.
There is absolutely zero evidence that Omni/Malecon has entered bankruptcy. If that happened it would need to be announced to shareholders and there would be a public record. It is likely that Malecon sold its book of prescriptions to Walgreens and intends to use the funds to acquire other business(es), more than likely, following through on it's plan to purchase one or more clinics as previously announced. Whether it's successful in doing so is a separate question.
News 
Market Data 
Discover 
